Does Intensive Glucose Control Cancel Out Benefits of Systolic Blood Pressure Target <120 mmHg in Patients With Diabetes Mellitus Participating in ACCORD?

被引：2
|
作者：
Kjeldsen, Sverre E. [1 ,2 ]
Os, Ingrid [1 ,3 ]
Nilsson, Peter M. [4 ]
机构：
[1] Univ Oslo, Inst Clin Med, Oslo, Norway
[2] Oslo Univ Hosp Ulleval, Dept Cardiol, Kirkeveien 166, N-0407 Oslo, Norway
[3] Oslo Univ Hosp Ulleval, Dept Nephrol, Oslo, Norway
[4] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden
来源：
HYPERTENSION | 2018年 / 72卷 / 02期
关键词：
RANDOMIZED-TRIAL; RISK; HYPERTENSION; AMLODIPINE; OUTCOMES;
D O I：
10.1161/HYPERTENSIONAHA.118.11455
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
[No abstract available]
引用
收藏
页码：291 / 293
页数：3
相关论文
共 50 条
  • [1] How to identify which patients should not have a systolic blood pressure target of <120 mmHg
    Spence, J. David
    Muller, Lucas O.
    Blanco, Pablo J.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (06) : 538 - 539
  • [2] Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus
    Almalki, Ziyad S.
    Iqbal, Mohammed Shahid
    Alablan, Faisal M.
    Alenazi, Raed K.
    Tasha, Abdullah R.
    Daghar, Mohammed F.
    Aldossary, Naif M.
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2020, 21 : 157 - 163
  • [3] Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus
    Verdecchia, Paolo
    Angeli, Fabio
    Reboldi, Gianpaolo
    [J]. HYPERTENSION, 2015, 66 (06) : 1104 - 1105
  • [4] Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus (vol 21, pg 157, 2020)
    Almalki, Z. S.
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 149 - 149
  • [5] Intensive Blood Pressure Control and Diabetes Mellitus-Related Limb Events in Patients With Type 2 Diabetes Mellitus: Reanalysis of ACCORD
    Tran, Kenneth
    Stedman, Margaret
    Chang, Tara I.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (15):
  • [6] Intensive blood pressure control in patients with and without type 2 diabetes mellitus: An analysis of SPRINT and ACCORD BP
    Buckley, Leo
    Dixon, Dave
    Wohlford, George
    Wijesinghe, Dayanjan
    Baker, William
    Van Tassell, Benjamin
    [J]. PHARMACOTHERAPY, 2017, 37 (12): : E143 - E144
  • [7] Effects of intensive control of blood glucose and blood pressure on microvascular complications in patients with type Ⅱ diabetes mellitus
    Cai-Hong Zhu
    Shi-Sheng Zhang
    Yan Kong
    Yu-Fang Bi
    Ling Wang
    Qiong Zhang
    [J]. International Journal of Ophthalmology, 2013, (02) : 141 - 145
  • [8] Effects of Intensive Blood Pressure Control in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Mancia, Giuseppe
    [J]. CIRCULATION, 2010, 122 (08) : 847 - 849
  • [9] Costs Associated With Delivering Intensive or Standard Glucose, Lipids, and Systolic Blood Pressure Control Strategies in the ACCORD Trial
    Zhang, Ping
    Hire, Don
    Hwang, Wenke
    Raisch, Dennis
    O'Connor, Patrick J.
    Narayan, K. M. Venkat
    Mohammed, Ali
    Thomas, Abraham
    Simmons, Debra
    Fine, Lawrence
    Anderson, Roger
    Sullivan, Mark
    [J]. DIABETES, 2013, 62 : A53 - A53
  • [10] Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic Control
    Tsujimoto, Tetsuro
    Kajio, Hiroshi
    [J]. HYPERTENSION, 2018, 72 (02) : 323 - 330
12345